Skip to main content

Table 1 Summarized data of OAB patients (Group 1, Group 1A = wet OAB, Group 1B = dry OAB)) and control group (Group 2) (f = female, m = male, y = years)

From: Changes in prostaglandin E2 in patients with idiopathic overactive bladder syndrome after botulinum toxin type A treatment: is there a clinical benefit?

Group

Age (y, range)

Gender

Age (y, range)

OAB-Group

Gender

Age (range)

1 (n = 56)

63 (18–87)

48 f

63.6 (18–87)

1A (n = 44)

40 f/4 m

63 (18–83)

8 m

62 (57–80)

1B (n = 12)

8 f/4 m

64 (40–87)

1 postop (n = 30)

62.1 (40–83)

25 f

59.6 (40–83)

1A (n = 25)

21 f/4 m

63.6 (28–83)

8 m

74.2 (67–80)

1B (n = 5)

4 f/1 m

60.4 (40–67)

2 (n = 31)

59 (21–72)

19 f

62 (28–71)

   

12 m

56.3 (21–65)